Literature DB >> 5121650

Azotomycin (NSC-56654): biologic fate in mice and man.

R F Pittillo, C Woolley, R W Brockman, D H Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5121650

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  3 in total

1.  Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.

Authors:  R H Earhart; D J Amato; A Y Chang; E C Borden; M Shiraki; M E Dowd; R L Comis; T E Davis; T J Smith
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON).

Authors:  A Rahman; F P Smith; P T Luc; P V Woolley
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  Biological assay of streptonigrin (NSC 45383) in body fluids and tissues of mice.

Authors:  R F Pittillo; C Woolley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.